SCHEMBL2439922

SCHEMBL2439922

O=[PH](Oc1ccc(O)cc1)Oc1ccc(O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
ESR2 Q92731 2/20 0.50
ESR1 P03372 2/20 0.50
LTA4H P09960 3/20 0.42
NR1H2 P55055 1/20 0.42
BAX Q07812 1/20 0.42
KDM4E B2RXH2 2/20 0.42
LMNA P02545 2/20 0.42
HIF1A Q16665 2/20 0.42
NPC1 O15118 1/20 0.42
CA12 O43570 1/20 0.42
GMNN O75496 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA3 P07451 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
TYR P14679 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27966252 0.93 ESR2 (0.52) MEN1KMT2AESR2ESR1LTA4H
SCHEMBL10295109 0.91 LTA4H (0.58) MEN1KMT2AESR2ESR1LTA4H
SCHEMBL12646235 0.85 MMP3 (0.52) MEN1KMT2AESR2ESR1LTA4H
Phenol SCHEMBL27580067 0.83 CA12 (0.50) ESR2ESR1LTA4HNR1H2BAX
SCHEMBL4104276 0.82 MEN1 (0.48) MEN1KMT2AESR2ESR1LTA4H
SCHEMBL27675950 0.81 LTA4H (0.46) MEN1KMT2AESR2ESR1LTA4H
SCHEMBL23777845 0.80 MEN1 (0.46) MEN1KMT2AESR2ESR1LTA4H
SCHEMBL20300 0.78 ALDH1A1 (0.59) MEN1KMT2AESR2ESR1LTA4H
SCHEMBL12841693 0.78 ESR1 (0.52) MEN1KMT2AESR2ESR1LTA4H
Zinc Ion SCHEMBL30690395 0.78 MEN1 (0.44) MEN1KMT2AESR2ESR1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119024654-A Method for forming pattern 三星SDI株式会社 2024-11-26 CN claimed
CN-115232401-A High-temperature-resistant flame-retardant foaming polypropylene master batch and preparation method thereof 江苏中科聚合新材料产业技术研究院有限公司 2022-10-25 CN claimed
WO-2007021598-A1 COMPOSITION FOR TREATING GLASS FIBERS AND TREATED GLASS FIBERS ACULON, INC. (US) 2007-02-22 WO claimed
US-20070036973-A1 Composition for treating glass fibers and treated glass fibers ACULON, INC. 2007-02-15 US claimed
CN-122029970-A Photoelectric conversion element and solar cell module 株式会社安能科多科技 2026-05-12 CN disclosed
CN-119790328-A Light-absorbing composition, light absorber, optical filter, ambient light sensor, imaging device, method for producing light-absorbing composition, and method for producing light absorber 日本板硝子株式会社 2025-04-08 CN disclosed
CN-119404118-A Light absorber, light-absorbing compound, dispersion of light-absorbing compound, light-absorbing composition, optical filter, photoelectric conversion element, ambient light sensor, and imaging device 日本板硝子株式会社 2025-02-07 CN disclosed
CN-119024654-A Method for forming pattern 三星SDI株式会社 2024-11-26 CN disclosed
CN-117642655-A Laminate, gaze tracking system, and head mounted display 富士胶片株式会社 2024-03-01 CN disclosed
CN-117441219-A Electrolyte for electrolytic capacitor, electrolytic capacitor using the same, and hybrid electrolytic capacitor 三洋化成工业株式会社 2024-01-23 CN disclosed
CN-116325164-A Optical filter, optical device, and light-absorbing composition 日本板硝子株式会社 2023-06-23 CN disclosed
CN-115073854-B High-temperature-resistant flame-retardant polypropylene foam material and preparation method and application thereof 江苏中科聚合新材料产业技术研究院有限公司 2022-11-25 CN disclosed
US-20060199788-A1 Anti-inflammatory phosphonate compounds GILEAD SCIENCES, INC. 2006-09-07 US disclosed
EP-1663254-A2 ANTI-INFLAMATORY PHOSPHONATE CONJUGATES GILEAD SCIENCES, INC. (US) 2006-06-07 EP disclosed
US-20060035866-A1 Phosphonate compounds having immuno-modulatory activity GILEAD SCIENCES, INC. 2006-02-16 US disclosed
EP-1620110-A2 IMMUNOMODULATOR PHOSPHONATE CONJUGATES GILEAD SCIENCES, INC. (US) 2006-02-01 EP disclosed
WO-2004100960-A2 ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS GILEAD SCIENCES, INC. (US) 2004-11-25 WO disclosed
WO-2004096236-A2 IMMUNOMODULATOR PHOSPHONATE CONJUGATES GILEAD SCIENCES, INC. (US) 2004-11-11 WO disclosed
US-5216113-A Flameproofing additives with resistance to thermal aging and migration BAYER AKTIENGESELLSCHAFT (DE) 1993-06-01 US disclosed
US-4093588-A Hindered phenolic cyclic phosphonates and stabilized compositions CIBA-GEIGY CORPORATION (US) 1978-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060035866-A1 Phosphonate compounds having immuno-modulatory activity PHOSPHO1, NFATC1, IFNG MEN1 3346/4885KMT2A 3968/4885ESR2 2842/4885
US-20060199788-A1 Anti-inflammatory phosphonate compounds PHOSPHO1, TNF, PTGES MEN1 4122/4885KMT2A 4832/4885ESR2 577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.